METHOD FOR DETERMINING EXPRESSION OF THE MODIFYING ACTIVITY ASSOCIATED WITH CARRIER Russian patent published in 2018 - IPC G01N33/15 

Abstract RU 2643934 C2

FIELD: pharmacology.

SUBSTANCE: invention relates to pharmacology and can be used to determine the extent of modifying activity, associated with the carrier acquired in during processing of the initial substance in form of repeated successive reduction of its concentration using a carrier, which manifests itself in the ability to directly change physico-chemical and/or biological properties of initial substance when exposed to it by said carrier. For this purpose presence or absence of molecules of the initial substance in said carrier is determined, and in presence of molecules of the initial substance before measurement of the characteristic parameter molecules of the initial substance are removed from the carrier, and one or more characteristic parameters of the initial substance are measured by analytical methods before and after interaction with said carrier, wherein, degree of modifying activity expression is determined by magnitude of the change in the characteristic parameter in relative units of activity calculated by formula (1): X=C|A-AM|:A, (1), where X is the number of units of activity (UA); C is the dimensionless coefficient of proportionality; A is value of the characteristic parameter of the initial substance prior to interaction of said activated carrier with it; AM is the value of the same characteristic parameter of the initial substance after interaction of the above activated carrier with it.

EFFECT: invention allows to determine the extent of modifying activity associated with the carrier, acquired during processing of the initial substance in form of repeated successive reduction of the concentration of the latter using a carrier.

4 cl, 1 dwg, 4 tbl, 7 ex

Similar patents RU2643934C2

Title Year Author Number
METHOD FOR DETERMINATION OF EXPRESSION OF MODIFYING ACTIVITY ASSOCIATED WITH CARRIER 2013
  • Epshtejn Oleg Ilich
RU2643936C2
MEDICINAL AGENT FOR TREATING INFECTIOUS DISEASES 2014
  • Epshtejn Oleg Ilich
  • Tarasov Sergej Aleksandrovich
RU2579262C1
METHOD FOR TREATING INFECTIOUS DISEASES AND COMPLEX MEDICATION FOR TREATMENT OF INFECTIOUS DISEASES 2011
  • Epshtejn Oleg Ilich
  • Tarasov Sergej Aleksandrovich
RU2577299C2
THERAPEUTIC AGENT 2013
  • Epshtejn Oleg Ilich
RU2595809C2
THERAPEUTIC AGENT FOR TREATING PATHOLOGICAL SYNDROME AND METHOD OF TREATING MULTIPLE SCLEROSIS 2011
  • Ehpshtejn Oleg Il'Ich
RU2519196C2
COMBINED DRUG FOR TREATING BACTERIAL INFECTIONS AND METHOD OF TREATING BACTERIAL INFECTIONS 2010
  • Ehpshtejn Oleg Il'Ich
RU2502521C2
THERAPEUTIC AGENT AND METHOD FOR PREVENTION OF HIV INFECTION AND TREATMENT OF HIV-CAUSED OR HIV-ASSOCIATED DISEASES, INCLUDING AIDS 2010
  • Ehpshtejn Oleg Il'Ich
  • Tarasov Sergej Aleksandrovich
RU2535033C2
THERAPEUTIC AGENT FOR TREATING INFECTIOUS DISEASES 2014
  • Epshtejn Oleg Ilich
  • Tarasov Sergej Aleksandrovich
RU2595807C2
METHOD AND COMPOSITION FOR PREVENTING HIV INFECTION, PREVENTING AND TREATING HIV-CAUSED OR HIV-ASSOCIATED DISEASES, INCLUDING AIDS 2010
  • Ehpshtejn Oleg Il'Ich
  • Tarasov Sergej Aleksandrovich
  • Strygin Andrej Valer'Evich
RU2516931C2
DRUG PREPARATION FOR TREATING INFECTIOUS DISEASES ACCOMPANIED BY NEUROTOXIC DISORDERS, AND METHOD OF TREATING INFECTIOUS DISEASES ACCOMPANIED BY NEUROTOXIC DISORDERS 2010
  • Ehpshtejn Oleg Il'Ich
RU2446821C2

RU 2 643 934 C2

Authors

Epshtejn Oleg Ilich

Dates

2018-02-06Published

2013-02-19Filed